Fructose-1,6-bisphosphate and MK-801 by aortic arch flush for cerebral preservation during exsanguination cardiac arrest of 20 min in dogs. An exploratory study

Resuscitation

Volumn 50, Issue 2, 2001, Pages 205-216

  Behringer, Wilhelm ^a   Kentner, Rainer ^a   Wu, Xianren ^a   Tisherman, Samuel A ^a,b   Radovsky, Ann ^a   Stezoski, William S ^a   Henchir, Jeremy ^a   Prueckner, Stephan ^a   Jackson, Edwin K ^b   Safar, Peter ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Brain ischemia; Cardiac arrest; Cardiopulmonary resuscitation; NMDA receptor; Trauma

Indexed keywords

DIZOCILPINE; FRUCTOSE BISPHOSPHATASE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; ARTICLE; BRAIN DEATH; CARDIOPULMONARY BYPASS; CIRCULATION; CONTROLLED STUDY; DOG; FEMORAL ARTERY; FLUSHING; HEART ARREST; HEART PERFUSION; HISTOLOGY; HYPOTHERMIA; INTENSIVE CARE; MALE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RESUSCITATION; TISSUE PRESERVATION;

ANIMALS; AORTA, THORACIC; CARDIOPULMONARY BYPASS; CARDIOPULMONARY RESUSCITATION; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOGS; FRUCTOSE-BISPHOSPHATASE; HEART ARREST; HEMORRHAGE; HYPOTHERMIA, INDUCED; HYPOXIA, BRAIN; NEUROPROTECTIVE AGENTS; PULMONARY EDEMA; REPERFUSION; TREATMENT OUTCOME;

EID: 0034852382     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(01)00337-9     Document Type: Article

References (69)

1. Suspended animation for delayed resuscitation
2. Resuscitation from clinical death: Pathophysiologic limits and therapeutic potentials
3. Hypothermic aortic arch flush for preservation during exsanguination cardiac arrest of 15 min in dogs
4. Adenosine by aortic flush fails to augment the brain preservation effect of mild hypothermia during exsanguination cardiac arrest in dogs - An exploratory study
5. Mild hypothermic aortic arch flush improves neurologic outcome from exsanguination cardiac arrest in dogs
6. Rapid induction of mild cerebral hypothermia by cold aortic flush achieves normal recovery in a dog outcome model with 20-min exsanguination cardiac arrest
7. Rapid hypothermic aortic flush can achieve survival without brain damage after 30 min cardiac arrest in dogs
8. Emergency cardiopulmonary bypass for resuscitation from prolonged cardiac arrest
9. Profound hypothermia (less than 10°C) compared with deep hypothermia (15°C) improves neurologic outcome in dogs after 2 h circulatory arrest induced to enable resuscitative surgery
10. Complete recovery after normothermic hemorrhagic shock and profound hypothermic circulatory arrest of 60 min in dogs
11. Thiopental and phenytoin by aortic arch flush for cerebral preservation during exsanguination cardiac arrest of 20 min in dogs. An exploratory study
12. Exploration of pharmacologic aortic arch flush strategies for rapid induction of suspended animation (SA, cerebral preservation) during exsanguination cardiac arrest (ExCA) of 20 min in dogs
13. Fructose1,6 biphosphate (FBP) by aortic arch flush for cerebral preservation during 20 min exsanguination cardiac arrest (CA) in dogs
14. Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose-1,6-diphosphate
15. Effects of fructose-1,6-diphosphate, glucose, and saline on cardiac resuscitation
16. Neuroprotective activity of fructose-1,6-bisphosphate following transient forebrain ischemia in the Mongolian gerbil
17. Effects of fructose-1,6-bisphosphate on brain polyamine biosynthesis in a model of transient cerebral ischemia
18. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil
19. MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period
20. The relationship of structural ischemic brain damage to neurobehavioural deficit: The effect of postischemic MK-801
21. Pre- and post-ischemic administration of dizocilpine (MK-801) reduces cerebral necrosis in the rat
22. Combined treatment with MK-801 and nicardipine reduces global ischemic damage in the gerbil
23. Limited but evident protective effects of MK-801 and pentobarbital on neuronal damage following forebrain ischemia in the gerbil under normothermic conditions
24. MK-801 (dizocilpine) protects the brain from repeated normothermic global ischemic insults in the rat
25. Role of the excitotoxic mechanism in the development of neuronal damage following repeated brief cerebral ischemia in the gerbil: Protective effects of MK-801 and pentobarbital
26. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia
27. Effect of excitatory amino acid receptor blocker MK-801 on overall, neurologic, and morphologic outcome after prolonged cardiac arrest in dogs
28. Effect of delayed MK-801 (dizocilpine) treatment with or without immediate postischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats
29. Combined postischemic hypothermia and delayed MK-801 treatment attenuates neurobehavioral deficits associated with transient global ischemia in rats
30. Hypertension with or without hemodilution after cardiac arrest in dogs
31. Cerebral blood flow promotion after prolonged cardiac arrest
32. Regional prevalence and distribution of ischemic neurons in dog brains 96 h after cardiac arrest of 0-20 min
33. Global brain ischemia: A reproducible monkey model
34. Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs
35. Long-term animal outcome models for cardiopulmonary-cerebral resuscitation research
36. Fructose-1,6-bisphosphate after hypoxic ischemic injury is protective to the neonatal rat brain
37. Fructose-1,6-bisphosphate reduces infarct volume after reversible middle cerebral artery occlusion in rats
38. The effects of dizocilpine maleate (MK-801), an antagonist of the N-methyl-D-aspartate receptor, on neurologic recovery and histopathology following complete cerebral ischemia in primates
39. Resuscitation of the ischemic brain
40. Failure of a multifaceted anti-reoxygenation injury (RI) therapy to ameliorate brain damage after ventricular fibrillation (VF) cardiac arrest (CA) of 20 min in dogs
41. Effective combination treatments for cerebral resuscitation from cardiac arrest in dogs. Exploratory studies
42. Thiopental combination treatments for cerebral resuscitation after prolonged cardiac arrest in dogs. Exploratory outcome study
43. Fructose-1,6-bisphosphate protects astrocytes from hypoxic damage
44. Fructose-1,6-bisphosphate reduces ATP loss from hypoxic astrocytes
45. Energy metabolism in hypoxic astrocytes: Protective mechanism of fructose-1,6-bisphosphate
46. Mechanism of the effect of exogenous fructose 1,6-bisphosphate on myocardial energy metabolism
47. Inhibition of proteinase K by phosphorylated sugars
48. Effects of fructose-1,6-biphosphate on microsphere-induced cerebral ischemia in the rat
49. Fructose-1,6-bisphosphate, when given immediately before reoxygenation, or before injury, does not ameliorate hypoxic ischemic injury to the central nervous system in the newborn pig
50. Fructose-1,6-diphosphate, when given 5 min after injury, does not ameliorate hypoxic ischemic injury to the central nervous system in the newborn pig
51. Fructose-1,6-bisphosphate does not ameliorate hypoxic ischemic injury to the central nervous system in the newborn pig
52. Fructose-1,6-bisphosphate fails to ameliorate delayed neuronal death in the CA1 area after transient forebrain ischaemia in gerbils
53. The effect profound hypothermia on preservation of cerebral ATP content during circulatory arrest
54. The effects of anesthesia and hypothermia on canine cerebral ATP and lactate during anoxia produced by decapitation
55. Prolonged severe hemorrhagic shock and resuscitation in rats does not cause subtle brain damage
56. Exsanguination versus ventricular fibrillation cardiac arrest in dogs: Comparison of neurologic outcome-preliminary data
57. Response of cerebral endothelial cells to hypoxia: Modification by fructose-1,6-bisphosphate but not glutamate receptor antagonists
58. Protection of astrocytes by fructose 1,6-bisphosphate and citrate ameliorates neuronal injury under hypoxic conditions
59. Effects of neuroprotective dose of fructose-1,6-bisphosphate on hypoxia-induced expression of c-fos and hsp70 mRNA in neonatal rat cerebrocortical slices
60. Fructose-1,6-bisphosphate preserves adenosine triphosphate but not intracellular pH during hypoxia in respiring neonatal rat brain slices
61. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist
62. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil
63. The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats
64. Lack of protection by the N-methyl-D-aspartate receptor blocker dizocilpine (MK-801) after transient severe cerebral ischemia in the rat
65. Evaluation of the glutamate antagonist dizocilipine maleate (MK-801) on neurologic outcome in a canine model of complete cerebral ischemia: Correlation with hippocampal histopathology
66. MK-801, an excitatory amino acid antagonist, does not improve neurologic outcome following cardiac arrest in cats
67. Suppression of postischemic epileptiform activity with MK-801 improves neural outcome in fetal sheep
68. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia
69. Suspended animation for delayed resuscitation from prolonged cardiac arrest that is unresuscitable by standard cardiopulmonary-cerebal resuscitation